Body aches as worsened; headache was reported as worsened; This non-serious case was reported by a other health professional via sales rep and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 13-JAN-2025, the patient received Shingrix. In JAN-2025, an unknown time after receiving Shingrix, the patient experienced general body pain (Verbatim: Body aches as worsened) and headache (Verbatim: headache was reported as worsened). The outcome of the general body pain and headache were not resolved. The reporter considered the general body pain and headache to be related to Shingrix. The company considered the general body pain and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 14-JAN-2025 The patient received Shingrix and had body aches and headache. Body aches and headache was reported as worsened. The patient had subsequent dose of Shingrix.

Customer calling to report temperature excursion. PROQUAD dose was administered on 1/23/2025.; This spontaneous report was received from an Other Health Professional and referred to a patient of unknown age and gender. The patient’s medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 23-JAN-2025, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #Y010050, expiration date: 25-NOV-2025, administered for prophylaxis (strength, and route of administration were not provided) (product storage error).

The patient has not report and medical concerns or symptoms regarding this report; Pharmacist stated that a 61 year old patient was concomitantly administered VARIVAX and MMR II during the same vaccination appointment today; This spontaneous report was received from a pharmacist and refers to a 61-year-old of unknown gender.The patient’s medical history, concurrent conditions, and concomitant therapies were not reported. On 28-JAN-2025, during the same vaccination appointment, the patient was concomitantly vaccinated with a both varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter/two dose series and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 0.5 milliliter /two dose series, administered for prophylaxis (strengths, lot numbers, expiry dates, and routes of administration were not provided) (product administered to patient of inappropriate age ). It was confirmed the patient has not report and medical concerns or symptoms regarding this report (no adverse event). No additional information provided. Additional information is not expected.

No additional AE; HCP called to report a 11-year-old patient was administered PROQUAD, when she was only due for Varicella vaccine. Inquiring about the validity of the Varicella and potential side effects of additional MMR II. See request cases, 02741163 and 0271190.; This spontaneous report was received from Other Health Professional (Medical Assistant) and refers to an 11-year-old female patient. The patient’s pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On 22-JAN-2025, the patient was vaccinated with measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) injection, lot #X026597, expiration date: 11-MAY-2025, administered for prophylaxis (strength, dose, route of administration, and anatomical site of injection were not provided). The patient was only due for the varicella vaccine, but the combination vaccine (PROQUAD) was administered instead (wrong product administered). Additionally, the patient was vaccinated with sterile diluent (MERCK STERILE DILUENT) solution for injection/infusion (strength, dose description, lot #, expiry date, route of administration, and indication were not provided). No additional adverse events were reported (no adverse event). No additional information was available.

N/A; received wrong vaccine for age group

The next day ( 01/18/2025) following the vaccine, patient experienced bruising, swelling, inflamed area, pain. The next following days ) 01/18-23/ 2025) patient kept experiencing pain, new sign of itching and redness and on day 5 post vaccines the swelling increased, pain reaching the elbow. Patient went primacy doctor who prescribed oral antibiotic, topical steroid and pain medication.

Rash below injection site that started the day after injection. Infection and was given Augmentin 875 mg twice daily for 7 days. Swollen arm. Hot around injection site. Couldn’t move or lift arm on day after vaccine.

syncope after getting IMZ, EMS cleared patient to follow up with primary, primary suggested walk-in clinic, walk-in said to go to ER since patient hit her head

ADMINISTRATION ERROR. DUPLICATE VACCINE. RECEIVED SEPTEMBER 2023

red, itchy hive-like rash on neck, back, and hip. pt stated it began about 1 week after the vaccine was administered. used an OTC “itch cream” on it which did help. rash is still present. Advised patient to consult their prescriber to determine if the vaccine caused the reaction, and if patient should receive the second dose in the series.